Biotechnology Research
Boston, Massachusetts
11-50 employees
Founded Oct 2019
About PostEra
PostEra is a biotechnology company using Proton, its proprietary AI platform for medicinal chemistry, to accelerate the discovery of new medicines. It provides AI-driven drug discovery services and enters into co-discovery partnerships with pharmaceutical and biotech organizations to advance small-molecule and antibody-drug conjugate (ADC) programs. By closing the design-make-test cycle, PostEra aims to bring novel therapeutics to patients faster.
Company Classification
Customer Types
B2BB2G
Business Models
ServicesLicensing
Product & Service Types
AI-powered drug discovery servicesMedicinal chemistry AI platformTherapeutic co-discovery partnerships
Funding
Total Funding
$26.45M
No. of Funding Rounds
4
Customers
| Customer | Success Story | Source |
|---|---|---|
| Entered into a multi-year agreement with PostEra to leverage the Proton AI platform for small‑molecule drug discovery. | ||
| Funded a $68 million collaboration with PostEra to develop antivirals against pandemic viruses using the Proton AI platform. | ||
Nice Try Sign up to Ethos to access the full customer list Sign up to Ethos | Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. | Source |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos